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A B S T R A C T
Staphylococcus haemolyticus is a skin commensal emerging as an opportunistic pathogen. Nosocomial isolates of
S. haemolyticus are the most antibiotic resistant members of the coagulase negative staphylococci (CoNS), but
information about other S. haemolyticus virulence factors is scarce. Bacterial membrane vesicles (MVs) are one
mediator of virulence by enabling secretion and long distance delivery of bacterial effector molecules while
protecting the cargo from proteolytic degradation from the environment. We wanted to determine if the MV
protein cargo of S. haemolyticus is strain specific and enriched in certain MV associated proteins compared to the
totalsecretome.
The present study shows that both clinical and commensal S. haemolyticus isolates produce membrane ve-
sicles. The MV cargo of both strains was enriched in proteins involved in adhesion and acquisition of iron. The
MV cargo of the clinical strain was further enriched in antimicrobial resistance proteins.
Data are available via ProteomeXchange with identifier PXD010389.
Biological significance: Clinical isolates of Staphylococcus haemolyticus are usually multidrug resistant, their main
virulence factor is formation of biofilms, both factors leading to infections that are difficult to treat. We show
that both clinical and commensal S. haemolyticus isolates produce membrane vesicles. Identification of staphy-
lococcal membrane vesicles can potentially be used in novel approaches to combat staphylococcal infections,
such as development of vaccines.
1. Introduction
Staphylococcus (S) haemolyticus is a skin commensal which has
gained increased attention as an opportunistic pathogen, particularly in
patients with reduced immune defence and implanted medical devices.
Coagulase negative staphylococci (CoNS) are a leading cause of sepsis,
and S. haemolyticus is the second most frequently isolated CoNS from
blood culture after Staphylococcus epidermidis [1]. Nosocomial isolates
of S. haemolyticus are the most antibiotic resistant members of the
coagulase negative staphylococci (CoNS) [2], but little is known about
other factors involved in the transition from a “benign” skin commensal
to an invasive lifestyle.
Secreted and cell surface expressed bacterial proteins are known to
be major determinants of virulence and pathogenicity, and are the first
to interact with host cells [3]. In Staphylococcus aureus which has a
plethora of virulence factors and immune evasive factors, secreted
proteins interact with the host immune defence in several ways [4].
CoNS are less virulent in comparison to S. aureus, but the phenol soluble
modulins (PSMs) of several CoNS have been described as important
virulence factors promoting sepsis and biofilm development [5]. Re-
cently a novel α-type PSM with pronounced cytolytic capacity was
identified in addition to the three known PSMβ1-3 in S.haemolyticus
culture filtrates [6].
Another mediator of bacterial virulence is membrane vesicles
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(MVs). Although MVs have been thoroughly described in Gram-nega-
tive bacteria, they were only recently discovered in Gram-positive
bacteria [7,8]. MVs are spherical bi-layered structures of 20–100 nm
that are produced and released during bacterial growth. The MVs en-
able secretion and long distance delivery of bacterial effector molecules
while protecting the cargo from proteolytic degradation from the en-
vironment. Proteomic and functional analyses have revealed that MVs
are enriched in proteins involved in virulence, antimicrobial resistance,
microbe-host interaction and inter- bacterial communication, they can
also act as decoys, thereby protecting the bacteria against host im-
munity and phage infections [9–11]. Both in S. aureus and in a sepsis
strain of S. epidermidis, MVs were enriched in proteins characterized as
virulence factors [12,13].
In this study we show for the first time that S. haemolyticus produces
MVs. We further perform a comparative analysis of the MV cargo and
the total secretome of a commensal and clinical isolate with respect to
identification of strain specific and MV associated proteins. Previous
studies did not perform a comparative analysis between the MV cargo
and the total secretome. The results obtained through this study provide
information about S. haemolyticus strain specific protein expression,
which might reflect differences in the genetic background and gene
expression of a clinical blood culture isolate and a skin isolate.
2. Materials and methods
2.1. Bacterial strains and culture conditions
One clinical S. haemolyticus blood culture isolate from a neonatal
sepsis episode at a Paediatric ward at a Norwegian hospital, was used.
This isolate, 51–08 is Methicillin resistant and also resistant to genta-
micin, fusidic acid, macrolides, tetracycline and fluoroquinolones. The
strain has been sequenced, and the sequence is deposited at the
European Nucleotide Archive with the number (7067_4_39,
ERS066281) [14]. The S. haemolyticus commensal isolate 57-1 was
isolated from swabbing the armpit of a healthy adult, not exposed to
antibiotics during the three previous months prior to sampling. The
commensal strain, 57-1 was sensitive to all 11 antimicrobial agents
tested [2]. Strain 57-1 is also sequenced, but the sequence is not yet
published. The bacteria were picked from blood agar plates, and grown
overnight in Tryptic Soy Broth (TSB, Becton Dickinson, Franklin Lakes,
USA) at 37 °C. Overnight cultures were diluted 1:100 in 100ml TSB (for
isolation of proteins released by the bacteria into the supernatant) or in
1000ml TSB (for isolation of membrane vesicles) and grown to OD600
of 2.0 ± 0.2.
2.2. Isolation of MVs from culture supernatants
Bacterial cultures at OD600 of 2.0 ± 0.2 were pelleted by cen-
trifugation (5000 g, for 20min, at 4 °C), and the supernatant was fil-
tered through a 0.22 μm polyethersulfone membrane (Millipore express
plus, Merck Millipore, Burlington, USA), before being concentrated
using Amicon Ultra-15, 100 kDa, centrifugation units (Millipore express
plus, Merck Millipore, Burlington, USA). Membrane vesicles were iso-
lated by ultracentrifugation at 164, 326× g (40. 000 rpm, using SW 60
Ti rotor from Beckman Coulter Brea, USA) for 2 h at 4 °C. The pellet was
re-suspended in ice-cold Phosphate buffer saline (PBS) and further
purified by gradient centrifugation. Thereto, the samples were mixed
with OptiPrep TM (Sigma-Aldrich, Steinheim, Germany) to a final
concentration of 30%, loaded to the bottom of a tube and further
layered with 2000 μl 25% and 1000 μl 5% OptiPrep TM. The MV frac-
tions were separated by density gradient centrifugation at an average of
84, 168 x g (30. 000 rpm, using SW 50 Ti rotor from Beckman Coulter,
Brea, USA) for 3 h at 4 °C. Fractions were then collected from the top.
The presence of proteins in the different fractions was determined by
SDS-PAGE followed by Coomassie blue staining (BioRad, Hercules,
USA). OptiPrep fractions were analysed by transmission electron
microscopy (TEM) for confirmation of MV content and sample purity.
Further, fractions containing MVs were pooled and diluted in 4ml PBS,
before centrifugation using a Vivaspin 4 turbo tube (Sartorius,
Göttingen, Germany) at 5000 x g for 30min in order to remove residual
OptiPrep solution. The sterility of the isolated MV samples was verified
by streaking small aliquots on blood agar plates followed by incubation
at 37 °C overnight and further examined for growth of bacteria on the
blood agar plate. All experiments were performed as three independent
biological replicates, performed at three independent time points, using
three independent starting cultures.
2.3. Transmission electron microscopy and atomic force microscopy
analysis
MV samples were prepared for transmission electron microscopy
(TEM) analyses using a standard negative stain method. 5 μl of the MV
sample was applied to a formvar coated 75 mesh hexagonal copper
grid. The grids were washed four times with ddH2O and transferred to a
0.3% solution of uranyl acetate in 1.8% methylcellulose. The grids were
then left to dry before microscopy. Electron micrographs were recorded
using a JEOL JEM1010 microscope (Akishima, Japan), at 80 kV accel-
eration voltage.
For atomic force microscopy (AFM) analysis of whole cells of S.
haemolyticus, the strain was grown overnight on Luria Bertani (LB) agar
plates.
Sample preparation was carried out as described previously [15].
Representative images were collected by a nanoscope V atomic force
microscope (Bruker AXS, Billerica, USA).
2.4. Protein precipitation and sample preparation for mass spectrometry
Proteins from culture filtrates and pooled MV fractions were pre-
cipitated and sample preparation was performed as described pre-
viously in [16]. Protein concentration was determined using the Qubit
TM protein quantification kit (Thermo Fisher Scientific, Waltham,
USA). Four μg of protein was reduced and alkylated with dithiothreitol
and iodoacetoamide, respectively, prior to digestion with a 1:20 ratio of
trypsin (V511A, Promega, Madison, USA). The resulting peptide mix-
ture was purified and desalted using OMIX C18 tips (Varian, Inc., Palo
Alto, USA) and dried in a speed vacuum centrifuge. Dried peptides were
dissolved in 0.2% formic acid.
2.5. Protein identification and analysis by mass spectrometry
Mixtures of 2 μg peptides in 0.2% formic acid were loaded onto a
Thermo Fisher Scientific EASY-nLC1000 system with an EASY-Spray
column (C18, 2 μm, 100 Å, 50 μm, 50 cm). Peptides were fractionated
using a 2–100% acetonitrile gradient in 0.1% formic acid over 50min at
a flow rate of 250 nl/min. The gradient had four steps; an 8min gra-
dient step from 4 to 8% acetonitrile followed by a 50min step from 8 to
40% acetonitrile, a 8min step to 100% acetonitrile and a final 8min
step at 100%. The separated peptides were analysed using a Thermo
Scientific Q-Exactive mass spectrometer. Tandem mass spectra were
collected in data-dependent acquisition (DDA) mode using a Top10
method.
2.6. Protein analysis and label-free data analysis
The raw data were processed in the MaxQuant software v1.6.0.16
using label-free intensity based absolute quantification (iBAQ). MS/MS
data were searched against the custom in-house databases of predicted
protein sequences encoded by S. haemolyticus 51-08 (ERS066281, 2527
coding DNA sequences) and S. haemolyticus 57-1 (genome assembly not
published, 2518 coding DNA sequences). The false discovery rate (FDR)
was controlled using a target-decoy approach and limited to 1%. The
quantitative comparison of proteins in the two different bacterial
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strains was performed using the relative iBAQ values (riBAQ) in Perseus
programme v1.5.6.0 [17], filtered for proteins with minimum two
peptides identified. All contaminants were first filtered out and the
relative iBAQ values for each sample were log10 transformed. The ra-
tios of proteins enriched in vesicles were then calculated using non-
transformed riBAQ values. Data were then analysed for statistically
significant changes using t-test. Only proteins identified in at least two
replicates in at least one of the two groups were considered. Missing
values were replaced from normal distribution using width=0.3 and
downshift = 1.8 settings. Differentially expressed proteins were then
visualized using Volcano plot with FDR < 0.05 and artificial within
group variance s0=0.3. For qualitative comparisons, only proteins
present in at least two replicates in each group were considered further.
2.7. Bioinformatic analyses
The cellular localisation of each protein was predicted using the
PSORTb subcellular localisation tool version 3.0.2 [18]. The presence of
potential signal sequences in each peptide was identified using SignalP
v4.1 [19,20]. Secretome P v2.0 was used to predict nonclassical protein
secretion [21]. Functional annotation and grouping of proteins into
orthologous groups were performed using EggNOG version 4.5.1 [22].
Proteins classified as hypothetical proteins by EggNOG were further
analysed by using NCBI Conserved Domains [23]. Venn diagrams were
made using the online tool Venny v2.1.0 [24].
3. Results
3.1. S. haemolyticus releases membrane vesicles
In order to evaluate whether S. haemolyticus produces MVs, AFM
analysis of bacteria grown on agar plates were performed. The com-
mensal strain of S. haemolyticus is surrounded by blebs that appear as
vesicles (Fig. 1A) as previously demonstrated by AFM images of MV
blebbing in S. aureus [13]. To study this further, MVs were isolated from
a commensal and a clinical strain and purified further by gradient
centrifugation, to remove contaminating proteins and cellular debris.
The various fractions in the gradient were evaluated for protein content
by SDS-PAGE see Fig. 1A in [25] and for presence of MVs by TEM
analysis. TEM analysis showed that MVs appeared in fractions 2–7, and
these fractions were therefore pooled. The size of S. haemolyticus MVs
were evaluated by TEM, and ranged from 20 to 180 nm (Fig. 1B).
3.2. Characterisation of MV- associated proteins in clinical and commensal
strain
We wanted to analyse and compare the proteins associated with the
MVs from the commensal and clinical strain of S. haemolyticus. MVs
purified by density gradient were precipitated, and the proteins asso-
ciated with MVs identified by mass spectrometry. Based on the detec-
tion of the protein in at least two of the three parallel experiments, 313
and 440 see Table 1 in [25] proteins were identified in the MV fractions
of the clinical and the commensal strain respectively. The two strains
shared 268 MV associated proteins (Fig. 2A), while the clinical and
commensal strain had 73 and 206 unique proteins, respectively, see
Table 2 in [25].
The proteins were further grouped into orthologous groups by
EggNOG. The overall protein distribution was similar in the two strains,
with a high proportion of proteins with unknown function, and proteins
involved in translation, ribosomal structure and biogenesis and amino
acid transport and metabolism (Fig. 2B). Several lipoproteins involved
in iron and cation acquisition and transport were found in the MV cargo
of both strains. In both strains we identified the surface protein SasC
and two proteins with a LysM motif, allowing non covalent attachment
to the cell wall, in addition to several cytoplasmic proteins with known
moonlighting functions see Table 2 in [25].
Proteins involved in intracellular trafficking and vesicular transport
were found only in the MV cargo of the clinical strain. Proteins only
found in the MVs of the commensal strain were involved in Cell cycle
control, cell division, chromosome partitioning; nucleotide transport
and metabolism; post-translational modification, protein turnover and
chaperones and signal transduction mechanisms. Moreover, the MV
cargo of the clinical strain was associated with more proteins involved
in defence mechanisms, replication, recombination and repair, trans-
lation, ribosomal structure and biogenesis, transcription, cell wall/
membrane/envelope biogenesis and proteins of unknown function,
compared to the low virulent commensal strain (Fig. 2B). The com-
mensal isolate had more proteins involved in energy production and
conversion, inorganic ion transport and metabolism, and amino acid
transport compared to the clinical strain (Fig. 2B).
Among the unique MV associated proteins of the clinical strain,
proteins involved in antimicrobial resistance were found. Beta lacta-
mase class A and D, hydrolysing the ring of beta lactam antibiotics, the
penicillin binding protein mecA and AACA-APH conferring resistance to
aminoglycosides see Table 2 in [25]. The beta lactamase as well as two
Fig. 1. S. haemolyticus releases membrane vesicles in vitro. A: Atomic force microscopy images of MVs from an S. haemolyticus clinical strain grown on LB agar plates.
Arrows indicate surrounding membrane vesicles. B: TEM of purified MVs from the commensal S. haemolyticus strain.
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proteins with an LPXTG motif known to mediate covalent attachment to
the cell wall in adhesive proteins were among the top 10 most abundant
proteins in vesicles from this strain (Table 1).
Of particular interest are several proteins involved in uptake of iron
found in the MVs from the commensal strain see Table 2 in [25]. Two
proteins with an YSIRK/LPXTG motif, were also identified among the
most abundant proteins in MVs of the commensal strain (Table 1). The
EggNOG analysis classified several proteins with unknown function
(Fig. 2B). Manual BLAST and Conserved domain searches of the pro-
teins with unknown function identified them as originating from bac-
teriophages, and as proteins containing LPXTG, YSIRK motifs, which
are abundantly found in the vesicles see Table 2 in [25].
The sub-cellular localisation and origin of the MV associated pro-
teins from the two strains were analysed by the PSORTB software. The
majority of the identified MV associated proteins in both strains were
classified as cytoplasmic proteins (50% and 71% from the clinical and
commensal strain respectively), as shown in Fig. 3. The clinical strain
had higher proportion of extracellular as well as cell wall proteins and
proteins with un-classified localization, compared to the commensal
strain (Fig. 3). In contrast, the commensal had a higher proportion of
cytoplasmic proteins associated with membrane vesicles compared to
the clinical strain (Fig. 3).
The identified MV associated proteins were further analysed by
SignalP and SecretomeP. SignalP predicts presence and location of
signal-peptide cleavage sites in the protein sequences, while
SecretomeP predicts non-classical protein secretion. Signal P predicted
that 7.0% and 4.6% of the clinical and commensal MVs associated
proteins had a signal peptide, respectively. Similarly, the analysis with
Table 1
The ten most abundant MV associated proteins uniquely identified in the S.haemolyticus strains. Proteins written in bold are genes and proteins of particular interest
due to their virulence or antimicrobial resistance properties.
Gene identifier NCBI accession Gene name Protein description Major function
S. haemolyticus clinical strain
7067_4_39_Contig_79_gene_1 WP_103416081.1 NA Collagen binding protein Adhesion
7067_4_34_Contig_11_gene_24 WP_279808 SH2354 Major capsid protein Phage related
7067_4_34_Contig_11_gene_53 WP_279808 SH1792 Single-strandedDNA-binding protein DNA binding
7067_4_39_Contig_11_gene_25 WP_053019334 SH0936 Hydroxyacyl-[acyl-carrier-protein] dehydratase Lipid synthesis
7067_4_39_Contig_57_gene_4 WP_279808 SH1764 Beta-lactamase Response to antibiotic
7067_4_39_Contig_14_gene_39 WP_033079618 SH0827 30S Ribosomal protein S10 Translation
7067_4_34_Contig_67_gene_1 WP_279808 SH2426 YSIRKsignal domain/LPXTG Adhesion
7067_4_39_Contig_11_gene_5 WP_279808 SH2355 Uncharacterised protein Viral scaffold
7067_4_39_Contig_8_gene_66 WP_087503638 SH0181 3-methyl-2-oxobutanoate hydroxymethyltransferase Coenzyme transport
7067_4_39_Contig_11_gene_54 WP_049426210 AL487_004505 Single-strandedDNA-binding protein DNA binding
7067_4_39_Contig_29_gene_28 WP_279808 SH1546 Tautomerase Isomerase
S. haemolyticus commensal strain
SH_1_Contig_14_gene _74 WP_011275085.1 CHAP-domain containing protein Surface antigen NA
SH_1_Contig_1_gene _112 WP_053022007.1 AL487_004355 Phage capsid protein Capsid protein
SH_1_Contig_1_gene _97 WP_049395108.1 SH2368 Trimeric dUTPase dUTP diphosphatase activity
SH_1_Contig_1_gene _77 WP_06631851.1 Q4L341 Single strand binding protein DNA binding
SH_1_Contig_1_gene _110 WP_033079738.1 SH0576 Gluconate permease Transmebrane transport
SH_1_Contig_1_gene _111 WP_070499237.1 SH2358 Phage terminase DNA packaging
SH_1_Contig_1_gene _106 WP_070487579.1 B8W97_13505 Phage holin Phage related functions
SH_1_Contig_4_gene _25 WP_037550722 DUF 1229 DUF domain protein NA
SH_1_Contig_1_gene _103 WP_107634554.1 DUF722 DUF domain protein NA
SH_1_Contig_1_gene _54 WP_053018964.1 SH1816 Thioredoxin Cell redox homeostasis
Fig. 2. Functional classification of proteins identified in membrane vesicles. A: VENN diagram showing number of shared and unique proteins associated with
membrane vesicles from the clinical and the commensal strain. B: EggNOG based classification of proteins (%) associated with the MVs of the two strains.
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SecretomeP predicted that 2.2% and 9.9% of the MV-associated pro-
teins in the clinical and commensal strain respectively, were non-clas-
sically secreted proteins.
3.3. Characterisation of total secretome
We also wanted to compare the total secretome (TS) of the two S.
haemolyticus strains. The bacterial culture filtrates were precipitated
and the proteins were analysed by MS. In total 241 and 493 proteins
were identified in the supernatant of the clinical isolate and the com-
mensal isolate respectively, and among them 199 proteins were shared
see Tables 1 and 3 in [25].
The distribution of clusters of orthologous groups (COG) in the total
secretome from the two isolates was overall similar. The majority of
proteins belonged to the COG groups translation, ribosomal structure
and biogenesis, amino acid transport and metabolism, energy produc-
tion and conversion, and function unknown (Fig. 4). When comparing
the COG distribution of total secretome between the two strains, the
clinical strain had more proteins classified as involved in defence me-
chanisms, cell wall/membrane/envelope biogenesis and function un-
known compared to the commensal strain. In contrast, the commensal
strain had more proteins classified as proteins involved in nucleotide
transport and metabolism, coenzyme transport and metabolism, trans-
lation, ribosomal structure and biogenesis and energy production and
conversion.
In order to further determine if the strain specific protein secretome
was due to the strain specific response to the growth conditions, func-
tional classification was performed for the total proteome encoded in
the genomes of the two strains, and further compared to the strain
specific secreted proteins. The proteomes, predicted from the genome
sequences of the two strains are very similar. The observed differences
in secreted proteins, as shown in Fig. 4, might be due to a differential
gene expression of the two strains.
The most abundant proteins identified in the secretome of both
strains were Phenol soluble modulin (PSM) beta 1–3 and PSM α see
Table 3 in [25]. The cytoplasmic proteins glyceraldehyde −3-phos-
phate- isomerase (GAPHD), enolase, aldolase, glucose-6-Phosphate
isomerase, Inosine 5` monophosphate, GroEL, triose-phosphate-iso-
merase and glutamine synthetase were found in the TS of both strains.
These proteins are known to have dual function and are denoted as
moonlighting proteins.
Moreover, the clinical isolate had 42 strain specific proteins while
the commensal isolate had 294 strain specific proteins in the TS.
Proteins associated with antimicrobial resistance (penicillin binding
proteins) and proteins with LPXTG/YSIRK motifs were detected in the
TS of the clinical strain, among the top ten most abundant proteins
three proteins with adhesive properties were found (Table 2).
The commensal strain had more proteins in the TS associated with
acquisition of iron compared to the clinical isolate, among the top ten
most abundant proteins were several ribosomal proteins, and the
moonlighting protein Pyruvate dehydrogenase (Table 2).
3.4. S. haemolyticus MVs are enriched in certain proteins compared to
proteins detected in the total secretome
In order to determine if the S. haemolyticus MVs are indeed enriched
in virulence factors, we compared the MV cargo to the total secretome.
If proteins were detected with a threshold detection rate of FDR 0.05 in
the MV sample as compared to in the TS, these proteins were defined as
enriched.
The MV samples of the clinical and commensal strain were enriched
in 98 and 131 proteins compared to the TS see Table 4 and Figs. 1 and 2
Table 2
The ten most abundant proteins uniquely identified in the Total Secretome of the S.haemolyticus strains. Proteins written in bold are of particular interest due to their
virulence or antimicrobial resistance properties.
Gene identifier NCBI accession Gene name Protein description Major function
S. haemolyticus clinical strain
7067_4_39_Contig_79_gene_1 WP_103416081.1 NA Collagen binding protein Adhesion
7067_4_39_ Contig_4_gene_35 WP_011274688.1 NA Hypothetical protein NA
7067_4_39_Contig_41_gene_16 WP_037558933.1 NA Hypothetical protein NA
7067_4_39_Contig_41_gene_3 WP_016930889 NA Hypothetical protein NA
7067_4_39_Contig_67_gene_1 WP_01127668.1 NA YSIRKsignal domain/LPXTG anchor domain protein Adhesion
7067_4_39_Contig_4_gene_29 WP_053029024.1 NA LPXTG anchor protein Adhesion
7067_4_39_Contig_18_gene_52 WP_053019334.1 SH0936 3-hydroxyacyl-[acyl-carrier-protein] dehydratase Fatty acis biosynthesis
7067_4_39_ Contig_4_37 WP_016930626.1 NA Hypothetical protein NA
7067_4_39_Contig_11_gene_53 WP_053024457.1 NA HU family DNA binding protein DNA binding protein
7067_4_39_Contig_79_gene_1 WP_053017623 NA LysM, CHAP domain protein Adhesion
S. haemolyticus commensal strain
SH_Contig_1_gene_112 WP_053022007.1 NA Phage capsid protein NA
SH_Contig_14_gene_3 WP_011275150.1 SH0836 30S ribosomal protein S9 Translation
SH_Contig_1_gene_97 WP_049395108.1 SH 2368 dUTP phospahatase Polypeptide binding
SH_Contig_14_gene_30 WP_107641137.1 SH0805 50S ribosomal protein L22 Translation
SH_Contig_1_gene_77 WP_066031851.1 SH0983 Single strand DNA binding protein Dna binding
SH_Contig_16_gene_9 WP_053019334.1 SH0936 3-hydroxyacyl-[acyl-carrier-protein] dehydratase Fatty acid biosynthesis
SH_Contig_20_gene_8 WP_053018515 SH2467 50S ribosomal protein L7 Polypeptide binding
SH_Contig_1_gene_111 WP_107610065 SH1858 Pyruvate dehydrogenase Catalytic activity
SH_Contig_5_gene_111 WP_053027994.1 B8W97_11210 D-alanyl-D-alanine carboxypeptidase Peptidase
SH_Contig_3_gene_51 WP_016930747.1 NA Hypothetical protein NA
Fig. 3. Predicted subcellular origin using Psortb, of the MV associated proteins
isolated from the clinical and the commensal strain.
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in [25]. The MVs of both the clinical and the commensal strain were
enriched in LPXTG and LysM motif containing surface proteins, lipo-
proteins and proteins involved in uptake of iron.
The MVs from the clinical strain were also enriched in proteins in-
volved in antimicrobial resistance, beta lactamase blaZ, and AACA-APH
conferring resistance to beta lactams and aminoglycosides and the
moonlighting proteins aldolase and Inosine-6-P-isomerase see Table 4
in [25]. Among the top 20 most enriched proteins in the clinical strain
(Table 3), Lys M was found at a 24.4 times higher ratio in the MVs
compared to in the TS. Lys M is a protein known to confer cell wall
attachment to several surface proteins [26], and also confers adhesion
to fibrinogen and fibronectin [27]. Ferritin and iron (III) binding pro-
teins were found at 29.3 and 9.1 higher ratios in the MVs compared to
the TS while BlaZ was 29.1 times more abundantly found in the MVs
compared to the TS in the clinical strain.
In the commensal strain proteins with an LPXTG/YSIRK motif were
also among the 20 most abundantly enriched proteins in the MVs. The
surface proteins SraP and sasC were found 35.9 and 30.3 times more
abundantly in the MV compared to the TS, additionally two LPXTG
motif proteins were found at ratios 16 and 36 times more abundant in
the MVs compared to the TS (Table 3).
The moonlighting proteins GAPHD, Enolase and Pyruvate
dehydrogenase were also enriched in MVs of the commensal strain see
Table 4 in [25].
4. Discussion
Secretion of outer membrane vesicles by Gram-negative bacteria has
been known for decades and thoroughly described [28]. Several pub-
lications have demonstrated the importance of membrane vesicles in
bacterial communication, immune evasion, protection against anti-
microbial agents and implications in bacterial virulence [29–31]. The
production of membrane vesicles from Gram-positive bacteria was first
described in S. aureus by Lee et al. in 2009 and is now described in
several Gram positive bacteria [29,32,33]. In a study by Siljamaki et al.
2014, non-classical protein secretion in MVs was suggested for Sta-
phylococcus epidermidis [34].
4.1. Membrane vesicle content
S. haemoyticus is a part of the commensal flora and has few virulence
factors, compared to S. aureus. However, S. haemolyticus has over the
past decades emerged as an opportunistic nosocomial pathogen. We
were interested to know if the membrane vesicle cargo differed in a
Table 3
The 20 most abundantly enriched proteins identified in the membrane vesicles compared to the total Secretome of S.haemolyticus. Genes and proteins written in bold
are of particular interest due to their virulence or antimicrobial resistance properties.
Gene identifier NCBI accession riBAQ MV x/
y_riBAQ TS
Gene name Protein description
S. haemolyticus clinical strain 279808.SH2009
7067_4_39_Contig_15_gene_42 WP_011276276.1 36,5 PEPA 279808.SH0805 Aminopeptidase
7067_4_39_Contig_14_gene_43 WP_107641137.1 33,8 rplB 396513.Sca_0311 50S ribosomal protein L2
7067_4_39_Contig_21_gene_2 WP_015899569.1 33,6* LysM 279808.SH1764 lysM
7067_4_39_Contig_57_gene_4 WP_279808.1 31,3 BLAZ 279808.SH1060 Beta-lactamase
7067_4_39_Contig_6_gene_86 WP_107612164.1 29,3 FTNA 279808.SH1002 Bacterial non-heme ferritin
7067_4_39_Contig_6_gene_32 WP_011275310.1 22,5 groEL Q3L881 Chaperone
7067_4_39_Contig_14_gene_63 WP_053041491.1 22 rplM 2789808.SH2354 50 SRibosomal protein L13
7067_4_39_Contig_11_gene_24 WP_279808.1 20,5 279808.SH1856 Major capsid protein
7067_4_39_Contig_28_gene_23 WT_053024633.1 20,35 PDHD 2789808.SH2468 Dyhydrolipoyl dehydrogenase
7067_4_39_Contig_31_gene_20 WP_085060703.1 19,9 rplJ 2789808.SH1273 50S ribosomal protein L10
7067_4_39_Contig_10_gene_20 WP_066031883.1 17,3 rplU 2789808.SH1471 SH 1273, rplu,50s ribosomal protein
7067_4_39_Contig_87_gene_1 WP_011275766.1 14,7 2789808.SH2250 YSIRK containing signal peptide
7067_4_39_Contig_16_gene_23 WP_011276510.1 15,3 tagF 2789808.SH0836 Glycosyltransferase, group 2 family protein
7067_4_39_Contig_14_gene_72 WP_011275150 13,9 rpsI 2789808.SH0907 Ribosomal protein S9
7067_4_39_Contig_18_gene_23 WP_053019918.1 12,5 rpoE 2789808.SH2583 Probable DNA-directed RNA polymerase subunit delta
7067_4_39_Contig_21_gene_31 WP_053021514.1 11,2 guaB 2789808.SH1018 Inosine-5-monophosphate dehydrogenase
7067_4_39_Contig_6_gene_45 WP_104948354.1 9,76 bamJ 279808.SH0863 Aminotransferase
7067_4_39_Contig_38_gene_5 WP_011275175.1 9,1 FECB 279808.SH1975 Iron(III) dicitrate-binding protein
7067_4_39_Contig_15_gene_9 WP_011276242.1 9 clpB 1005058.UMN179_01656 Chaperone protein ClpB
7067_4_39_Contig_13_gene_27 WP_048667800 8,5 ALDA Q4L919 Aldehyde dehydrogenase
S.haemolyticus commensal strain
SH_1_Contig_30_gene_13 WP_011275438.1 144,6 PCKA 279808.SH1137 Phosphoenolpyruvate Carboxylase
SH_1_Contig_2_gene_35 WP_053041297.1 56,1 GBSA B8W97_04095 Betaine- Aldehyde Dehydrogenase
SH_1_Contig_17_gene_15 WP_053041210.1 40,7 NA B8W97_11220 Poly alpha -glucosyltransferase
SH_1_Contig_4_gene_143 WP_037569827.1 40 PEPA 279808.SH1177 Peptidase m42 family protein
SH_1_Contig_20_gene_16 WP_053023376.1 36,2 SASH 279808.SH2452 LPXTG surface 5'-nucleotidase
SH_1_Contig_2_gene_88 WP_053019568.1 35,9 SRAP 279808.SH0326 Serine-rich glycoprotein adhesin SraP family
protein
SH_1_Contig_1_gene_333 WP_053017719.1 32,9 YHFE 279808.SH1543 Metallo hydrolase
SH_1_Contig_3_gene_134 WP_048667800.1 32,6 ALDA 279808.SH0547 Aldehyde dehydrogenase
SH_1_Contig_21_gene_2 WP_011275466.1 30,3 SASC 279808.SH1165 YSIRK/LPXTG surface protein,
SH_1_Contig_11_gene_15 WP_053027580.1 26,8 SUCA 279808.SH1492 2-oxoglutarate dehydrogenase, E1
SH_1_Contig_22_gene_9 WP_011276736.1 23,9 CLPC 279808.SH2484 ATP-dependent Clp protease
SH_1_Contig_15_gene_22 WP_011276260.1 23,21 ROCD 279808.SH1993 Ornithine aminotransferase
SH_1_Contig_1_gene_246 WP_053024043 22,9 YMFH 279808.SH1634 Peptidase, M16
SH_1_Contig_3_gene_172 WP_011274837.1 22,9 NA 435838.HMPREF0786_01053 CHAP domain protein, Surface antigen
SH_1_Contig_1_gene_256 WP_053028931.1 22,6 PORA 279808.SH1624 Oxidoreductase
SH_1_Contig_8_gene_49 WP_011276401.1 22,3 RAIA 279808.SH2139 Ribosomal subunit Interface protein
SH_1_Contig_1_gene_76 BAE05102.1 20,36 STERM_0814 279808.SH1793 Erf family
SH_1_Contig_3_gene_164 WP_033079754.1 17,8 GLCB 279808.SH0358 The phosphoenolpyruvate-dependent sugar
phosphotransferase system
SH_1_Contig_17_gene_14 WP_048667926.1 16,3 SGAA 279808.SH1201 Aminotransferase, class V
SH_1_Contig_4_gene_120 OJH00147.1 16,33 NA 272620.KPN_00994 YSIRK domain surface protein
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commensal and a clinical strain of S. haemolyticus, and if we could
detect more proteins involved in virulence in the clinical strain com-
pared to the commensal strain.
Differences both in the number of proteins as well as in the protein
content were found.
The clinical strain had more proteins involved in antimicrobial re-
sistance such as MecA and BlaZ mediating antimicrobial resistance to
penicillin and methicillin and the bifunctional Aac-AphD which med-
iates antimicrobial resistance to gentamicin [14]. MVs have previously
been shown to carry functional antimicrobial resistance genes [35], and
in a proteomic analysis of the S. aureus and S. epidermidis MV cargo, the
presence of active beta lactamases was demonstrated [32,34,35].
Adhesion is one of the main virulence mechanisms of CoNS, as it is
the key step in colonization and infection [36]. YSIRK/LPXTG and LysM
motifs are characteristic for adhesive proteins, and proteins with an
LPTG/YSIRK/LysM motifs were enriched in the MV cargo of both
strains. Adhesion proteins have been found in the MVs of Pseudomonas
putida, Bacillus subtilis and in Escherichia coli where it was shown to
increase adherence to host cells [30,37,38]. Release of MVs has been
shown to increase during biofilm formation, indicating that they play
an important role of delivery of DNA and proteins to shape the biofilm
matrix [39,40]. Additionally MVs can act as a transport vehicle trans-
porting virulence factors and effector proteins in a protected manner
[41] mediating bacteria-bacteria interactions or bacteria –host inter-
actions [10].
In agreement with previous studies [8,34,42], we found an enrich-
ment of proteins involved in acquisition of iron in the MV cargo from
both strains. Free iron is a limiting factor for bacterial growth, and in
order to successfully proliferate on the human host several systems have
evolved to sequester iron [43,44]. Prados-Rosalez et al. demonstrated
that Mycobacterium tuberculosis produces MV packed with iron loaded
mycobactin, a protein able to transfer iron from chelators, and deliver
iron to adjacent bacteria under growth in iron limiting conditions [44].
Recently Lin et al. demonstrated that iron sequestering proteins are
released in outer membrane vesicles of Pseudomonas aeruginosa under
iron depleted growth circumstances [45].
The growth media used in this study is considered as a rich media,
however, the strains were grown to late exponential phase/early sta-
tionary phase when less iron was probably available due to the con-
sumption during growth. This might have induced the production of
proteins involved in iron uptake. Interestingly the highest number of
proteins involved in iron acquisition was found in MVs of the skin
commensal. The iron acquisition proteins are membrane anchored li-
poproteins, and has been shown to confer virulence and TLR2 activa-
tion in S.aureus [46]. Supply of free iron is a limiting factor for bacterial
growth, and both the clinical and the commensal strain should be able
to efficiently acquire iron in order to survive. Considering the different
environment encountered in the blood and on the skin, one can spec-
ulate that MVs are a more efficient strategy for iron acquisition on the
human skin, than in blood, resulting in the higher number of proteins
involved in iron acquisition in the commensal strain.
4.2. MVs are enriched in specific proteins
In order to determine if the S. haemolyticus MVs are enriched in
virulence factors, the strain specific MV cargo was compared to the
strain specific total secretome. An enrichment analysis of the MV pro-
teins showed that MVs in both strains were enriched in proteins in-
volved in iron acquisition, antimicrobial resistance and adhesion. The
identification of proteins involved in antimicrobial resistance in the
MVS of the clinical S. haemolyticus strain, reflects the highly antibiotic
resistant genotype and such pathogenesis –associated proteins have also
been shown in S. aureus MVs [47].
4.3. The most abundant proteins in the total secretome were phenol soluble
modulins
Interestingly the most abundant proteins in the total secretome in
both strains were the phenol soluble modulins β 1–3 and PSM α. It was
recently demonstrated that S. haemolyticus, in addition to PSM β 1–3,
produces a novel PSM α type, with pronounced cytolytic activity [6].
PSMs are produced by S. aureus and most CoNS, and are important
Fig. 4. EggNOG based classification of secreted proteins and proteome (based on genomes) of the two strains.
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mediators of virulence as cytolysins and attractants of neutrophils, cy-
tokine production and lysis of erythrocytes [48,49]. Moreover, it was
previously demonstrated that PSMs play an important role in staphy-
lococcal biofilm development and colonization [50]. In addition, the
strong surfactant property of PSMs can interact with the hydrophobic
compounds secreted from sebaceous glands on the skin, which might
enhance skin colonization by S. aureus [49]. It has previously been
showed that PSMs are produced in large quantities, being the most
abundant proteins in S. epidermidis culture supernatant [49].The
widespread production of PSMs in the less virulent commensal CoNS
species indicates that PSMs may play important roles in host coloni-
zation. This is in agreement with our results, where high levels of PSM β
1–3 and PSM α secretion was observed in both the commensal and in
the clinical strain.
4.4. Moonlighting proteins
A large proportion of the proteins in the total secretome and MVs
from both strains was of cytoplasmic origin, and the majority of the
proteins had no known motifs for surface export. The identification of
cytoplasmic proteins in the secretome and in the MVs can be explained
by cell lysis. However it has been shown that several cytoplasmic
proteins can function as moonlighting proteins, and that they are not
excreted due to cell lysis [51]. Moonlighting proteins often have dual
functions. While being engaged in cellular functions intracellularly they
often have important adhesive functions extracellularly [52]. Several of
the proteins found in both strains have previously been shown to have
moonlighting functions, such as ribosomal proteins, glyceraldehyde-3-
phosphate dehydrogenase (GAPHD) and enolase [52,53]. GAPHD,
fructose 1,6-bisphosphate aldolase and enolase were found in the TS
and in the MVs of both the commensal and the clinical strain and are
some of the best characterized moonlighting proteins. Studies have
shown that they are involved in adhesion to several serum proteins and
epithelial cells [53], which are important environmental constituents
for both the commensal and clinical S. haemolyticus isolate.
5. Conclusion
We show that both clinical and commensal S. haemolyticus isolates
produce membrane vesicles. Strain specific differences in secreted
proteins, as well as MV cargo were found. Proteins such as BlaZ, mecA
and Aac-AphD conferring antimicrobial resistance in addition to en-
riched proteins involved in adhesion was more abundantly found in the
MVs of the clinical strain, reflecting it's more virulent traits. The MVs of
both strains were enriched in proteins involved in acquisition of iron,
but the MVs of the commensal strain contained more of these proteins.
Thus, identification of staphylococcal membrane vesicles can po-
tentially be used in novel approaches to combat staphylococcal infec-
tions, such as development of vaccines.
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